Skip to content

Report Ocean Report Ocean Press Release We conducted a survey to understand the actual situation of the protein therapeutics market in 2022.

Dear members of the press
Report Ocean
[Report Ocean Press Release] We conducted a survey to understand the actual situation of the protein therapeutic drug market in 2022.
North America presented the global protein therapeutics market share in 2022. This is attributed to the increasing prevalence of chronic diseases, adoption of technologically advanced treatments, presence of major players, and rising healthcare costs in the region.
Survey overview:
Survey period: October 3, 2022 to December 30, 2022
Research agency :
Survey contractor: Report Ocean Co., Ltd.
In-house survey
Survey target: The survey was conducted with 890 leaders from organizations of all sizes around the world.
Number of valid responses: (890 people)
Survey method: Telephone survey of 300 people, Internet survey of 590 people Survey Respondents: The survey was conducted across companies based on revenue. [Image 1d67400-6000-a5eea30fa1a43eb1037b-0.png&s3=67400-6000-3613f043e95e28e77920f7cb147ba239-2700x1800.png
Investigation result :
Question: Which segment dominates the protein therapeutics market based on product?
Based on products, the monoclonal antibody segment dominated the market in 2022 due to the wide availability, importance, and applicability of these products in treating various chronic diseases. [Image 2d67400-6000-cf97836cdc2c8018b6d8-1.jpg&s3=67400-6000-dd65b6d9a169a8b0c4742d8e71b65803-1280x720.jpg
Question: Which segment dominates the protein therapeutics market based on application?
By application, the metabolic diseases segment is expected to dominate the market in 2022, driving growth in the segment due to the demand for high-quality drugs and versatile treatments for disease
treatments, especially diabetes. increase.
[Image 3d67400-6000-4819ef9331fdc3968b53-2.jpg&s3=67400-6000-f25f75ddbf73032cab08719dcdbde9c4-1280x720.jpg
Q: What are the key factors driving the protein therapeutics market? Growth in the protein therapeutics market is primarily driven by the rising prevalence of chronic diseases and the development of plasma-derived therapeutics. The increasing prevalence of various diseases, such as cancer, metabolic disorders, genetic disorders, and immune disorders, is expected to drive the demand for protein therapeutics. In addition, according to the World Health Organization (WHO), cancer is the leading cause of death in the world, and the number of cancer patients is expected to increase significantly in the future. Therefore, rising prevalence of cancer is expected to drive the protein therapeutics market.
In addition, increased proteomics research is another factor driving market growth. Protein microarrays enable parallel, high-throughput protein sorting. Many assays can be run on one small plate, saving researchers time and controlling experimental costs. Advances in proteomics research are expected to lead to an increase in the emergence of new protein pharmaceuticals, which may also be used to treat various diseases.
Survey conclusions:
According to the CXO, protein therapeutics are having a positive impact on many areas of disease treatment and prognosis. Otherwise debilitating and life-threatening diseases can be managed by administration of these drugs. It also plays an important role in prevention.
The CXO further said that the adoption rate of protein therapeutics is expected to be high due to the increase in defined indications and interventions such as lymphoma, diabetes, hepatitis and leukemia. Favorable government policies, regulatory compliance with protein therapeutics, and growth in proteomics research have seen significant momentum in the healthcare industry and pharmaceutical sector. However, high development and manufacturing costs, high treatment costs per patient, stringent government regulations, and complex reimbursement scenarios limit the market growth.
Emerging countries in Asia-Pacific and LAMEA have high potential for protein therapeutics. Growing awareness of chronic diseases and the use of proteins for the treatment of these diseases has led regulators in the region to make important decisions to improve protein therapeutics. Growth, increasing number of chronic diseases, and high demand for protein therapeutics are expected to boost the demand for these products in the coming years.
Read more:
about us:
We are the best market research report provider in the industry. Report Ocean believes in providing quality reports to clients to achieve top-line and bottom-line goals of increasing market share in today’s competitive environment. Report Ocean is a “one stop solution” for individuals, organizations and industries looking for innovative market research reports.
Details about this release: